Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Belkyra injections for hypogastric fat reduction
2018-001659-11Phase 3Completed
- Sponsor
- Cosmetic Surgery BCN
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Neobella in localized adiposity (AL), sponsored by Cosmetic Surgery BCN. Primary endpoint: Safety of Belkyra hypogastric injections. Started Jul 2018; status: completed.
02
Drugs
Neobella
03
Conditions
localized adiposity (AL)
Beyond the preview
Go deeper on 2018-001659-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001659-11.